US 11752202
Compositions and methods for treating hemoglobinopathies
granted A61KA61K31/7088A61K35/15
Quick answer
US patent 11752202 (Compositions and methods for treating hemoglobinopathies) held by Beam Therapeutics Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Beam Therapeutics Inc.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/7088, A61K35/15, A61K35/18, A61K35/28